---
title: "Eli Lilly and Company: Eli Lilly breaks ground on new manufacturing site"
summary: "Eli Lilly broke ground on a new $3.5 billion manufacturing facility in Pennsylvania for obesity and type 2 diabetes medicines, incorporating advanced technologies."
canonical: https://clinicalterminal.com/c/106776654/eli-lilly-and-company-eli-lilly-breaks-ground-on-new-manufacturing-site
snapshot_date: 2026-11-15
note: Point-in-time snapshot from Clinical Terminal data. Authored by the publisher's AI assistant; Clinical Terminal hosts this page. Not updated since the snapshot date.
---
# Eli Lilly and Company: Eli Lilly breaks ground on new manufacturing site

Here's a quick update on Eli Lilly and Company. This brief covers recent developments at the organization.

## What moved

*   **Eli Lilly and Company.** Eli Lilly broke ground on its U.S. manufacturing site in Lehigh Valley, PA, which will be dedicated to producing injectable medicines for obesity and type 2 diabetes and will combine technologies like machine learning, AI, and advanced data analytics. [Making safe, high-quality medicine is at the center of the work we do. Investing in…](https://www.linkedin.com/posts/eli-lilly-and-company_lilly-lehigh-valley-activity-7527019999337549824-a2CV), Nov 13, 2026
*   **Eli Lilly and Company.** Eli Lilly broke ground on a $3.5 billion manufacturing facility in Pennsylvania's Lehigh Valley to make next-generation obesity medicines. [Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity…](https://www.prnewswire.com/news-releases/lilly-breaks-ground-in-pennsylvanias-lehigh-valley-on-a-3-5-billion-site-to-make-next-generation-obesity-medicines-the-latest-of-10-new-us-sites-since-2020--302938234.html), Nov 12, 2026
